Contezolid, a novel oxazolidinone antibiotic, may improve drug-related thrombocytopenia in clinical antibacterial treatment

One of the major limitations in the clinical use of existing oxazolidinone antibiotics is their characteristic adverse reactions, in particular thrombocytopenia. In anti-infective treatment, if patients are suspected of having drug-induced thrombocytopenia, the first step is to immediately discontin...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Bi Li, Ying Liu, Jiaqi Luo, Yun Cai, Mengli Chen, Tianlin Wang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2023-04-01
Edice:	Frontiers in Pharmacology
Témata:	new oxazolidinone antibiotics contezolid drug-induced thrombocytopenia efficacy and safety case series
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1157437/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!